Scottsdale Healthcare, TGen partner on clinical research center
Summary:
Scottsdale Healthcare has been designated a primary clinic research site for the Translational Genomics Research Institute.
Full Story:
Scottsdale Healthcare has been designated a primary clinic research site for the Translational Genomics Research Institute.
Opening today, TGen Clinical Research Services will include a Genomics Medicine and Individual Therapy Center and a Pancreatic Cancer Center. It will be located in the Virginia G. Piper Cancer Center at Scottsdale Healthcare, and as it expands will move into the Cancer Center's Research Pavilion.
Dr. Daniel Von Hoff, director of TGen's translational drug development division will be the medical research leader of the center, which is funded by a $4.55 million grant from the Virginia G. Piper Trust.
"The TGen-Scottsdale Healthcare alliance embodies our vision of setting the standard for excellence in personalized healthcare," said Tom Sadvary, president and chief executive officer of Scottsdale Healthcare. "The combination of world-class researchers, community physicians, and university faculty in the Virginia G. Piper Cancer Center provides unprecedented access to new therapies for the citizens of Arizona."
Clinical trials with agents directed at specific targets in patients' tumors will be launched Nov. 1, 2005. Phase I clinical trials of two new cancer drugs will also be launched in November.
For more information:
"Scottsdale Healthcare, TGen open clinic sites," Arizona Republic, 10/20/2005